BackIbere Pharmaceuticals Overview
Ibere Pharmaceuticals - Class A

Ibere Pharmaceuticals PEG Ratio

Ibere Pharmaceuticals (IBER) has a PEG ratio of 631.84, above the sector sector average of 10.05.

Get informed when a big investor buys or sells

+ Follow

PEG Ratio

631.84

PEG Ratio

631.84

The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.

PEG Ratio (Comparison Companies)

Loading

PEG Ratio History

Loading

PEG Ratio Comparison

Loading

Ibere Pharmaceuticals (IBER) FAQ

As of the most recent data, IBER shows a PEG ratio of 631.84. That is above the sector sector average of 10.05. Scroll down for historical charts and peer comparison views.

The its sector sector average PEG ratio is about 10.05. Ibere Pharmaceuticals is at 631.84, which is higher that average. That is roughly 6183.9% above the sector mean. Use the comparison chart on this page to see how IBER stacks up against individual peers as well.

Investors watch IBER's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Ibere Pharmaceuticals's latest reading is 631.84. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this peg ratio page, Stockcircle has Ibere Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 631.84) with ownership activity and broader fundamentals.